Home > Formulary : Adult > Recent Decisions > 2016 >
Decisions 18th October 2016
At the meeting that took place on 18th October, the following decisions were agreed:
New Drug Requests
Approved
Dermatonics Heel balm® (TLS Blue)
- Approved for inclusion onto the formulary for diabetic patients at risk from ulceration under recommendation from podiatry services.
Betamethasone and calcipotriol (Enstilar® foam) (TLS Green)
- Approved for inclusion onto the formulary for the topical treatment of body psoriasis vulgaris in adults.
Esomeprazole granules (TLS Blue)
- Approved for inclusion onto the formulary for paediatric patients with NG tubes, or second line in children with swallowing difficulties.
Other
Guanfacine
- The JFG discussed the application but agreed to await the applicant to be present at the next meeting to make a final decision.
Rituximab
- The JFG agreed for rituximab in TTP to be included on the formulary for TTP as previously agreed at the Commissioning Advisory forum in 2011.
Shared Care Protocols/TLS Change in Status
- None